Notable Insider Buys: Biotech IPOs, Curiositystream, Greenbrier And More


Medic, Hospital, Laboratory, Medical, Health, Doctor

  • Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty.
  • Some insiders have taken advantage of recent biotech initial public offerings.
  • Some chief executives also stepped up to the buy window this past week.

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. So insider buying can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets or the markets at near all-time highs.

Here are some of the most noteworthy insider purchases that were reported in the past week.

Vor Biopharma Inc VOR saw two 10% owners acquire almost 3.5 million shares in its IPO. At an offering price of $18.00, the total for those purchases came to more than $63.63 million. Shares ended this past week trading at $48.78, after going as high as $63.62 after the IP

Lucira Health Inc LHDX had a 10% owner buy shares of in the initial public offering. The more than 3.46 million shares acquired, at $17.00 apiece, totaled nearly $58.85 million. The stock has traded as high as $35.72 so far and closed most recently at $33.49 per share.

CEO William Quinn acquired 1,200 Bolt Biotherapeutics Inc BOLT shares in the IPO, while other insiders bought up over 1.85 million shares. At $20.00 per share, those transactions totaled more than $37.12 million altogether. The stock closed most recently at $33.31 a share.

Three 10% owners picked up more than 1.61 million shares altogether of Terns Pharmaceuticals Inc TERN. That cost them more than $27.45 million, at the IPO price of $17.00 per share. Shares went as high as $23.68, before ending the week at $18.09 apiece.

In the wake of the Landos Biopharma Inc LABP IPO, a beneficial owner added to its stake. Almost 3.66 million shares were acquired at prices ranging from $10.96 to $16.00. That totaled over $22.90 million. The IPO price was $16.00, but the stock was last seen trading at $13.00.

1 2
View single page >> |

Disclosure: At the time of this writing, the author had no position in the mentioned equities.

© 2021 Benzinga does not provide investment advice. All rights ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.